Please enable JS

Finance & Investment (Pharma & Healthcare)

Title Published Pages Region Price
Global Gastric Cancer Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Clostridium difficile Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Non-Hodgkin Lymphoma Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Obesity Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Injectable Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts Sep 1 2018 230 Global $1,995.00
Global Esophageal Reflux Partnering 2012-2018 Sep 1 2018 100 Global $1,995.00
Global Osteoporosis Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Migraine Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Infectious Diseases Partnering 2012-2018: Deal trends, players and financials Sep 1 2018 800 Global $3,495.00
Global Transplantation Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Cervical Cancer Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Dengue Fever Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Acute and Chronic Myelogenous Leukemia Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Attention Deficit Disorder Partnering 2012-2018 Sep 1 2018 100 Global $1,995.00
Global Topical Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts Sep 1 2018 180 Global $1,995.00
Global Gastrointestinal Symptoms Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Osteoarthritis Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Multiple Sclerosis Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
Global Hospital Care Partnering 2012-2018: Deal trends, players and financials Sep 1 2018 900 Global $3,495.00
Global Accident & Emergency Partnering 2012 to 2018 Sep 1 2018 100 Global $1,995.00
Global Brain Cancer Partnering 2012 to 2018 Sep 1 2018 150 Global $1,995.00
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players May 4 2018 140 Global $2,995.00
Acne Vulgaris - Epidemiology Forecast to 2026 Mar 1 2018 37 Global $3,995.00
OpportunityAnalyzer: Late - Stage Chronic Kidney Disease - Opportunity Analysis and Forecasts to 2026 Dec 31 2017 195 Global $10,995.00
PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Drug Forecast and Market Analysis to 2026 Dec 20 2017 185 Global $10,995.00
PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2026 Dec 20 2017 280 Global $10,995.00
Global Allergy Partnering 2010 to 2017 Sep 1 2017 150 Global $1,495.00
Zeltia Partnering Deals and Alliances 2010 to 2017 Sep 1 2017 100 Global $1,495.00
Global Autoimmune Partnering 2010-2017: Deal trends, players and financials Sep 1 2017 700 Global $2,995.00
Galderma Partnering Deals and Alliances 2010 to 2017 Sep 1 2017 100 Global $1,495.00

Pages